Serclutamab talirine | EGFR inhibitor | Read Reviews & Product Use Citations

Serclutamab Talirine (ABBV-321), is an antibody-drug conjugate (ADC) composed of an humanized immunoglobulin G1 anti-EGFR monoclonal antibody conjugated to a pyrrolobenzodiazepine (PBD) dimer via a maleimidocaproyl-valine-alanine linker. Serclutamab Talirine has the potential for use in advanced solid tumors associated with overexpression of the epidermal growth factor receptor (EGFR) or its ligands.

CAS No. 2140174-56-5

Purity & Quality Control

Batch: D402701 Purity: 96.45% Protein concentration: 4.06mg/ml Endotoxin Level: ＜1EU/mg

96.45

Choose Selective EGFR Inhibitors

Biological Activity

Description	Serclutamab Talirine (ABBV-321), is an antibody-drug conjugate (ADC) composed of an humanized immunoglobulin G1 anti-EGFR monoclonal antibody conjugated to a pyrrolobenzodiazepine (PBD) dimer via a maleimidocaproyl-valine-alanine linker. Serclutamab Talirine has the potential for use in advanced solid tumors associated with overexpression of the epidermal growth factor receptor (EGFR) or its ligands.

Description

Serclutamab Talirine (ABBV-321), is an antibody-drug conjugate (ADC) composed of an humanized immunoglobulin G1 anti-EGFR monoclonal antibody conjugated to a pyrrolobenzodiazepine (PBD) dimer via a maleimidocaproyl-valine-alanine linker. Serclutamab Talirine has the potential for use in advanced solid tumors associated with overexpression of the epidermal growth factor receptor (EGFR) or its ligands.

References
[1] Carneiro BA, et al. Journal of Clinical Oncology 38, no. 15_suppl

References

[1] Carneiro BA, et al. Journal of Clinical Oncology 38, no. 15_suppl

Product Details

CAS No.	2140174-56-5
ADC antiody	Serclutamab
ADC cytotoxin	PBD
Formulation	1xPBS
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field